Page last updated: 2024-08-26

lopinavir and Diathesis

lopinavir has been researched along with Diathesis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Brynda, J; Kagan, RM; Konvalinka, J; Kozísek, M; Lepsík, M; Machala, L; Rezácová, P; Sasková, KG; Václavíková, J	1
Feng, X; Jiang, Y; Liu, C; Qu, F; Xi, H; Zhao, X; Zhao, Y	1

Reviews

1 review(s) available for lopinavir and Diathesis

Article	Year
Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020, Volume: 39, Issue:7 Topics: Angiotensin-Converting Enzyme 2; Anti-Inflammatory Agents; Antimalarials; Antiviral Agents; Basal Metabolism; Betacoronavirus; Cardiovascular Physiological Phenomena; Chloroquine; Congenital Abnormalities; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Disease Susceptibility; Drug Combinations; Drug Delivery Systems; Female; Functional Residual Capacity; Glycyrrhizic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Interferon Type I; Lopinavir; Metformin; Nanoparticles; Oxygen Consumption; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Progesterone; Prognosis; Respiratory Physiological Phenomena; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Stillbirth; Ventilation-Perfusion Ratio	2020

Article

Year

Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020, Volume: 39, Issue:7

Topics: Angiotensin-Converting Enzyme 2; Anti-Inflammatory Agents; Antimalarials; Antiviral Agents; Basal Metabolism; Betacoronavirus; Cardiovascular Physiological Phenomena; Chloroquine; Congenital Abnormalities; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Disease Susceptibility; Drug Combinations; Drug Delivery Systems; Female; Functional Residual Capacity; Glycyrrhizic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Interferon Type I; Lopinavir; Metformin; Nanoparticles; Oxygen Consumption; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Progesterone; Prognosis; Respiratory Physiological Phenomena; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Stillbirth; Ventilation-Perfusion Ratio

2020

Other Studies

1 other study(ies) available for lopinavir and Diathesis

Article	Year
Enzymatic and structural analysis of the I47A mutation contributing to the reduced susceptibility to HIV protease inhibitor lopinavir. Protein science : a publication of the Protein Society, 2008, Volume: 17, Issue:9 Topics: Alanine; Amino Acid Substitution; Catalysis; Computational Biology; Disease Susceptibility; Drug Resistance, Viral; Escherichia coli; HIV Protease; HIV Protease Inhibitors; Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Kinetics; Lopinavir; Models, Molecular; Protein Structure, Secondary; Pyrimidinones; Recombinant Proteins	2008

Article

Year

Enzymatic and structural analysis of the I47A mutation contributing to the reduced susceptibility to HIV protease inhibitor lopinavir.

Protein science : a publication of the Protein Society, 2008, Volume: 17, Issue:9

Topics: Alanine; Amino Acid Substitution; Catalysis; Computational Biology; Disease Susceptibility; Drug Resistance, Viral; Escherichia coli; HIV Protease; HIV Protease Inhibitors; Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Kinetics; Lopinavir; Models, Molecular; Protein Structure, Secondary; Pyrimidinones; Recombinant Proteins

2008